13F
中

ELTX ELICIO THERAPEUTICS INC

2026Q1 · CUSIP 28657F103 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
47
Δ holders QoQ
+10
Breadth percentile
Top 29%
Whale holders
27
Δ whales
+8
Inst. holding value
$28M
New positions
19
Closed positions
9
Price momentum (1Q)
—
Put / Call
4/3

Breadth history (34 quarters)

2023Q3: Δ+3 · h=19 2023Q4: Δ+0 · h=19 2024Q1: Δ+0 · h=19 2024Q2: Δ+2 · h=21 2024Q3: Δ-2 · h=19 2024Q4: Δ-1 · h=18 2025Q1: Δ+7 · h=25 2025Q2: Δ-3 · h=22 2025Q3: Δ+7 · h=29 2025Q4: Δ+8 · h=37 2026Q1: Δ+10 · h=47 2023Q3: holders=19 2023Q4: holders=19 2024Q1: holders=19 2024Q2: holders=21 2024Q3: holders=19 2024Q4: holders=18 2025Q1: holders=25 2025Q2: holders=22 2025Q3: holders=29 2025Q4: holders=37 2026Q1: holders=47 -10 -5 +0 +5 +10 163350 23Q323Q424Q124Q224Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 0 lit events

No lit events in history

Options Sentiment

Put holders
4
QoQ: +2
Call holders
3
QoQ: +2

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-2.36
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
2023-09-30: EPS -1.27 2024-03-31: EPS -1.15 2024-06-30: EPS -0.64 2024-09-30: EPS -1.39 2024-12-31: EPS -1.07 2025-03-31: EPS -0.87 2025-06-30: EPS -0.66 2025-09-30: EPS -0.60 2025-12-31: EPS -0.45 2026-03-31: EPS -0.65 -1.53 -0.76 0.00 20222023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)